Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)

BACKGROUND: Statins have been proved to be effective in reduction of mortality and morbidity when started in the early secondary prevention in stabilized patients after acute coronary syndrome (ACS). The safety and efficacy of statin administration directly in the first-line therapy in unstable ACS...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ostadal, Petr, Alan, David, Vejvoda, Jiri, Kukacka, Jiri, Macek, Milan, Hajek, Petr, Mates, Martin, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Holm, Frantisek, Telekes, Peter, Horak, David, Blasko, Peter, Zemanek, David, Veselka, Josef, Cepova, Jana
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2010
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886041/
https://ncbi.nlm.nih.gov/pubmed/20500832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-61
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky